Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Looking for Fingerprints: Bioanalytical Characterization of Biosimilars

June 02, 2012

Extensive physicochemical characterization of the innovator product and the proposed biosimilar provides the foundation for demonstrating biosimilarity.

Avoiding Contamination Risks in Aseptic Processes

June 02, 2012

How to avoid invisible and airborne contamination.

Innovation Boom Towns

June 02, 2012

Partnerships between industry and academic medical centers are expanding to meet R&D needs.

Advanced Tablet-Coating Technologies Aid Manufacturing Efficiency

June 02, 2012

New coating technologies achieve high uniformity and reduce waste through mixing system advances and pan and airflow configuration.

Biosimilar Developers Face a Reference-Product Dilemma

June 02, 2012

Does global development have to entail multiple comparability studies?

PDA Revises Technical Report on Sterilized Products

May 22, 2012

PDA Revises Technical Report on Sterilized Products

PDA Releases Technical Report on TBA and TCA Odors and Taints

May 22, 2012

The Parenteral Drug Association has released guidance on the detection and mitigation of 2,4,6-tribromoanisole and 2,4,6-trichloroanisole taints and odors in pharmaceutical and healthcare products.

Ongoing Challenges in Continuous Manufacturing

May 16, 2012

Equipment and Processing Report

Advances in process analytical technology and in defining lots for release are key for enabling use of continuous processes in solid-dosage manufacturing.

Week of May 7, 2012: Coherus BioSciences, Daiichi Sankyo Form Biosimilar Pact; Sandoz Agrees to Acquire Fougera Pharmaceuticals; and More

May 10, 2012

Coherus BioSciences, Daiichi Sankyo Form Biosimilar Pact; Sandoz Agrees to Acquire Fougera Pharmaceuticals; and More.

Week of Apr. 30, 2012: AstraZeneca's CEO David Brennan to Retire; PRA, Amgen Reach New Biosimilar Agreement; and More

May 03, 2012

AstraZeneca's CEO David Brennan To Retire; PRA, Amgen Reach New Biosimilar Agreement; and More.